Live Breaking News & Updates on Quarter For Tarsus Pharmaceuticals|Page 2

Stay updated with breaking news from Quarter for tarsus pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Prelude Capital Management LLC

Prelude Capital Management LLC lowered its stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 6.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,365 shares of the company’s stock after selling 1,200 shares during the period. Prelude Capital Management […] ....

United States , Elizabeth Yeu Lin , William Blair , Aziz Mottiwala , Group Plc , American International Group Inc , Prelude Capital Management , News Ratings For Tarsus Pharmaceuticals Daily , Tarsus Pharmaceuticals Profile , Barclays Plc , Exchange Commission , Quarter For Tarsus Pharmaceuticals , Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Trading , Tarsus Pharmaceuticals Inc , Free Report , Capital Management , Employees Retirement System , General Group Plc , American International Group , International Group , Director Elizabeth Yeu Lin , Get Free Report , Visit Holdingschannel , Tarsus Pharmaceuticals Daily , Nasdaq Tars ,

Bobak R. Azamian Sells 8,000 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) CEO Bobak R. Azamian sold 8,000 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $17.23, for a total transaction of $137,840.00. Following the sale, the chief executive officer now owns 902,106 shares in the […] ....

United States , William Blair , Bobakr Azamian , Tarsus Pharmaceuticals , Group Plc , Tarsus Pharmaceuticals Inc , Quarter For Tarsus Pharmaceuticals , Institutional Trading Of Tarsus Pharmaceuticals , Simplex Trading , News Ratings For Tarsus Pharmaceuticals Daily , Securities Exchange Commission , Tarsus Pharmaceuticals Stock Performance , Royal Bank , Get Free Report , Exchange Commission , Employees Retirement System , General Group Plc , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Insider Trading , Nsider Trades ,

Insider Selling: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) CEO Sells 8,000 Shares of Stock

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) CEO Bobak R. Azamian sold 8,000 shares of the stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $17.23, for a total transaction of $137,840.00. Following the completion of the transaction, the chief executive officer now owns 902,106 shares […] ....

United States , William Blair , Bobakr Azamian , Institutional Investors Weigh In On Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Company Profile , Tarsus Pharmaceuticals Price Performance , Quarter For Tarsus Pharmaceuticals , Jefferies Financial Group Inc , News Ratings For Tarsus Pharmaceuticals Daily , Blackrock Inc , Vanguard Group Inc , Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Inc , Get Free Report , Financial Group , Exoduspoint Capital Management , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Insider Trading , Nsider Trades ,

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Director Elizabeth Yeu Lin Acquires 9,506 Shares

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) Director Elizabeth Yeu Lin bought 9,506 shares of the stock in a transaction on Tuesday, August 15th. The shares were bought at an average price of $16.80 per share, for a total transaction of $159,700.80. Following the completion of the transaction, the director now directly owns 15,866 […] ....

United States , William Blair , Elizabeth Yeu Lin , Tarsus Pharmaceuticals Price Performance , News Ratings For Tarsus Pharmaceuticals Daily , Simplex Trading , Tarsus Pharmaceuticals Inc , Swiss National Bank , Quarter For Tarsus Pharmaceuticals , Callan Capital , Janney Montgomery Scott , Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Company Profile , Hedge Funds Weigh In On Tarsus Pharmaceuticals , Cibc World Markets Corp , Get Free Report , Director Elizabeth Yeu Lin , Montgomery Scott , National Bank , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Insider Trading , Nsider Trades ,

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Director Elizabeth Yeu Lin Buys 9,506 Shares

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) Director Elizabeth Yeu Lin bought 9,506 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were acquired at an average cost of $16.80 per share, for a total transaction of $159,700.80. Following the purchase, the director now directly owns 15,866 […] ....

United States , William Blair , Elizabeth Yeu Lin , Tarsus Pharmaceuticals Price Performance , Goldman Sachs Group Inc , Quarter For Tarsus Pharmaceuticals , Royal Bank , Tarsus Pharmaceuticals , News Ratings For Tarsus Pharmaceuticals Daily , Hedge Funds Weigh In On Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Inc , Wells Fargo Company , Securities Exchange Commission , Get Free Report , Director Elizabeth Yeu Lin , Exchange Commission , Employees Retirement System , Sachs Group , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Insider Trading , Nsider Trades ,